Univest
Univest
  • Markets

HIMALAYA NUTRAVEDICS INDIA LIM (HNIL): Himalaya Nutravedics India Share Price Rises 12.8% Today

  • October 14, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Himalaya Nutravedics India Share Price
HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) share price rose to Rs 135.3 today, up 12.8% from the previous close. Market cap was Rs 105.63 crore.

Himalaya Nutravedics India Share Price is trading at Rs 135.3, up 12.8% from the previous close of Rs 119.95, while market capitalisation stands at Rs 105.63 Cr. The rise places HNIL among the stronger names in today’s move, but according to Univest data, the price event is confirmed, but no company-specific catalyst is established. That makes the stock relevant for readers tracking Himalaya Nutravedics India Share Price today, because the move is measurable, the valuation is visible and the healthcare backdrop can be compared with peer numbers. In current Univest coverage, the focus stays on verified price action, fundamentals and sector positioning rather than speculation. For investors watching Himalaya Nutravedics India Stock News, the next checkpoints are the day’s price range, the company’s valuation multiples and how its ratios compare with listed peers in Pharmaceuticals & Drugs.

In simple terms, the Himalaya Nutravedics India Share Price move is notable because it combines an intraday gain with a compact market capitalisation base. The latest Univest figures show a clear price rise without a stated company event, so the analysis remains grounded in observable numbers. That is also why Himalaya Nutravedics India Share Price Today attracts attention in a stock analysis format: it lets readers separate price action from interpretation and compare the stock with the healthcare sector on a factual basis.

Table of Contents

Toggle
  • Himalaya Nutravedics India Share Price Today: Price Action Analysis
  • HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Himalaya Nutravedics India
  • About Himalaya Nutravedics India
  • Frequently Asked Questions
    • Why is Himalaya Nutravedics India Share Price rising today?
    • What is the current Himalaya Nutravedics India Share Price?
    • What is the market capitalisation of Himalaya Nutravedics India?
    • What valuation does Himalaya Nutravedics India Share Price trade at?
    • What do EPS and book value mean for Himalaya Nutravedics India?
    • Does Himalaya Nutravedics India pay a dividend?
    • How does Himalaya Nutravedics India compare with healthcare peers?
    • What is the sector context for Himalaya Nutravedics India Share Price?
  • Track Himalaya Nutravedics India Share Price on Univest

Himalaya Nutravedics India Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 135.3
Previous Close Rs 119.95
Today's Move Rs 15.35 (+12.8%)
Open Rs 125
High Rs 138.9
Low Rs 123.75
Market Capitalisation Rs 105.63 crore
Market Cap Category Micro Cap

HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) rose to Rs 135.3 from the previous close of Rs 119.95, a move of Rs 15.35 or 12.8%. The stock opened at Rs 125, reached a high of Rs 138.9, recorded a low of Rs 123.75.

The Himalaya Nutravedics India Share Price moved higher today, opening at Rs 125, touching a high of Rs 138.9 and a low of Rs 123.75, and last trading at Rs 135.3. The day’s gain of Rs 15.35, or 12.8%, reflects the current price move versus the previous close, with market capitalisation at Rs 105.63 Cr. This is the core price action story for Himalaya Nutravedics India Share Price Today.

HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) Fundamental Analysis

Metric Value
Market Capitalisation Rs 105.63 crore
P/E Ratio 14.29x
P/B Ratio 2.46x
EPS Rs 8.39
Book Value Per Share Rs 48.69
Dividend Yield 0%

HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) fundamental metrics show P/E 14.29x, P/B 2.46x. Read together, these ratios describe the company’s position rather than a recommendation.

HIMALAYA NUTRAVEDICS INDIA LIM has a market capitalisation of Rs 105.63 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 14.29x, P/B at 2.46x should be read against the sector and peer benchmarks rather than as a standalone signal. According to latest Univest data, additional metrics include EPS of Rs 8.39, book value per share of Rs 48.69, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.72x, median ROE of 11.61%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 14.29x
Benchmark Median P/E 31.72x
Benchmark Average P/E 46.74x
Benchmark P/E Range 3.11x to 663.29x
Company P/B Ratio 2.46x
Benchmark Median P/B 2.91x
Benchmark Median ROE 11.61%
Benchmark Median ROCE 13.46%
Company Market Capitalisation Rs 105.63 crore
Benchmark Median Market Cap Rs 821.94 crore

HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) has a P/E ratio of 14.29x, which is below the benchmark median of 31.72x, a difference of -54.95%. The P/E comparison frames valuation; it is not a signal to buy or sell.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Sun Pharmaceutical Industries Ltd. SUNPHARMA 4,22,067.01 35.09 4.91 14.85 19.11
Divi's Laboratories Ltd. DIVISLAB 2,48,982.98 84.18 13.94 16.19 21.51
Torrent Pharmaceuticals Ltd. TORNTPHARM 1,77,974.12 80.83 19.64 26.76 19.27
Zydus Lifesciences Ltd. ZYDUSLIFE 1,13,615.69 25 4.18 19.69 21.39
Laurus Labs Ltd. LAURUSLABS 1,11,898.66 101.36 19.65 18.31 18.2

HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) has a P/E ratio of 14.29x compared with the displayed peer median of 80.83x. Peer multiples give relative context only, not a buy or sell view. HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) has a market capitalisation of Rs 105.63 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Himalaya Nutravedics India

  • Himalaya Nutravedics India Share Price is up 12.8% today, with the stock last trading at Rs 135.3 versus the previous close of Rs 119.95.
  • The day’s range for Himalaya Nutravedics India Share Price ran from Rs 123.75 to Rs 138.9, which keeps the move easy to track in Price Action terms.
  • Himalaya Nutravedics India Fundamental Analysis shows P/E of 14.29, P/B of 2.46, EPS of Rs 8.39 and book value of Rs 48.69.
  • Healthcare sector context matters because the company’s valuation sits below the same-industry median on both P/E and P/B.
  • Himalaya Nutravedics India Market Cap of Rs 105.63 Cr is well below the same-industry median benchmark, which keeps the stock in a distinct comparison bracket.

About Himalaya Nutravedics India

Himalaya Nutravedics India LIM operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company profile used in Univest coverage places it within a same-industry benchmark set, which makes the Himalaya Nutravedics India Share Price relevant for readers comparing valuation and market cap within the broader healthcare universe. The business description in this article remains limited to the verified sector and industry identity, along with the financial and market data points already outlined.

For investors, the important company-level context is that Himalaya Nutravedics India Share Price is not being analysed as a macro story or a technical setup. It is being read as a stock with a defined market cap, a measurable earnings multiple, a book value anchor and a peer group in the same industry. That is the clearest way to understand the company today through Univest.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

Why is Himalaya Nutravedics India Share Price rising today?

Ans. Himalaya Nutravedics India Share Price is up 12.8% today, but according to Univest data, the price event is confirmed, while no company-specific catalyst is established. The move is best read through price action and valuation.

What is the current Himalaya Nutravedics India Share Price?

Ans. Himalaya Nutravedics India Share Price is Rs 135.3 at the latest reading. It is higher than the previous close of Rs 119.95, and the stock has traded between Rs 123.75 and Rs 138.9 today.

What is the market capitalisation of Himalaya Nutravedics India?

Ans. Himalaya Nutravedics India Market Cap stands at Rs 105.63 Cr. That is the company’s current size measure in Univest coverage and helps place Himalaya Nutravedics India Share Price within the healthcare industry comparison set.

What valuation does Himalaya Nutravedics India Share Price trade at?

Ans. Himalaya Nutravedics India Share Price is associated with a P/E ratio of 14.29 and a P/B ratio of 2.46. Those figures can be compared directly with same-industry benchmarks and listed peers for context.

What do EPS and book value mean for Himalaya Nutravedics India?

Ans. EPS is Rs 8.39 and book value is Rs 48.69. EPS reflects earnings attributable to each share, while book value shows accounting net worth per share behind Himalaya Nutravedics India Share Price.

Does Himalaya Nutravedics India pay a dividend?

Ans. The dividend yield shown for Himalaya Nutravedics India Share Price is 0. That means no payout is reflected in the current figures, so readers should focus on price action, valuation and industry comparison instead.

How does Himalaya Nutravedics India compare with healthcare peers?

Ans. Himalaya Nutravedics India Share Price has a lower P/E and P/B than several peer names such as Sun Pharmaceutical Industries, Divi’s Laboratories and Laurus Labs. Its market cap is also smaller than those companies.

What is the sector context for Himalaya Nutravedics India Share Price?

Ans. Himalaya Nutravedics India Share Price sits in Healthcare and Pharmaceuticals & Drugs, where the same-industry benchmark spans 199 companies. Its P/E and P/B both sit below the industry median and average figures.

Track Himalaya Nutravedics India Share Price on Univest

Use HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

You can track Himalaya Nutravedics India Share Price on Univest for live share price, fundamental ratios, market capitalisation, sector context and peer comparison in one place. Univest also keeps the stock’s valuation profile and company overview easy to review whenever Himalaya Nutravedics India Share Price moves. For readers following Himalaya Nutravedics India Stock News, this helps keep today’s price rise and longer-term company context together.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply